|
|
Volumn 5, Issue 8, 1999, Pages 853-
|
|
Mechanisms of thalidomide teratogenecity [3]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
THALIDOMIDE;
T BOX TRANSCRIPTION FACTOR;
T-BOX TRANSCRIPTION FACTOR 5;
TERATOGENIC AGENT;
TRANSCRIPTION FACTOR;
TRANSCRIPTION FACTOR TBX5;
CLINICAL FEATURE;
CONGENITAL DEAFNESS;
EMBRYOPATHY;
ENCHONDRAL OSSIFICATION;
ERYTHEMA NODOSUM LEPROSUM;
GENE MUTATION;
GENETIC ASSOCIATION;
HOLT ORAM SYNDROME;
HUMAN;
LETTER;
ORGAN DISTRIBUTION;
OXIDATIVE STRESS;
PATHOGENESIS;
PRIORITY JOURNAL;
SKELETON MALFORMATION;
TERATOGENICITY;
BONE;
BONE DEVELOPMENT;
CHEMICALLY INDUCED DISORDER;
DRUG EFFECT;
GENETICS;
LIMB MALFORMATION;
NOTE;
PRENATAL DEVELOPMENT;
BONE AND BONES;
HUMANS;
LIMB DEFORMITIES, CONGENITAL;
OSTEOGENESIS;
T-BOX DOMAIN PROTEINS;
TERATOGENS;
THALIDOMIDE;
TRANSCRIPTION FACTORS;
|
|
EID: 0032799742
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/11273 Document Type: Letter |
|
Times cited : (6)
|
|
References (3)
|
